Journal:
:acta medica iranica
0
fardeen ali malayeri department of neurogenetics, iranian center of neurological research, imam khomeini hospital , tehran university of medical sciences, tehran, iran. and department of clinical biochemistry, isfahan pharmaceutical sciences research center, school of pharmacy and pharmaceutical sciences, isfahan university of medical sciences, isfahan, iran.
mojtaba panjehpour department of clinical biochemistry, isfahan pharmaceutical sciences research center, school of pharmacy and pharmaceutical sciences, isfahan university of medical sciences, isfahan, iran.
ahmad movahedian department of clinical biochemistry, isfahan pharmaceutical sciences research center, school of pharmacy and pharmaceutical sciences, isfahan university of medical sciences, isfahan, iran.
majid ghaffarpour iranian center of neurological research, imam khomeini hospital, tehran university of medical sciences, tehran, iran.
gholam reza zamani department of neurology, children medical center, school of medicine, tehran university of medical sciences, tehran, iran.
hajifaraj tabrizi department of medical genetics, school of medicine, tehran university of medical sciences, tehran, iran.
this study determines the value of linkage analysis using six rflp markers for carrier detection and prenatal diagnosis in familial dmd/bmd cases and their family members for the first time in the iranian population. we studied the dystrophin gene in 33 unrelated patients with clinical diagnosis of dmd or bmd. subsequently, we determined the rate of heterozygosity for six intragenic rflp marker...
